Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population

BACKGROUND AND OBJECTIVE: The 52-week IRIDIUM study demonstrated the efficacy of indacaterol acetate/glycopyrronium bromide/mometasone furoate (IND/GLY/MF) versus IND/MF and salmeterol xinafoate/fluticasone propionate (SAL/FLU) in patients with symptomatic asthma, despite long-acting β(2)-agonist/in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagara, Hironori, Barbier, Nathalie, Ishii, Tsuyoshi, Yoshisue, Hajime, Nikolaev, Ivan, Hosoe, Motoi, Gon, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Asthma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978265/
https://www.ncbi.nlm.nih.gov/pubmed/33737310
http://dx.doi.org/10.1136/bmjresp-2020-000856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978265/
https://www.ncbi.nlm.nih.gov/pubmed/33737310
http://dx.doi.org/10.1136/bmjresp-2020-000856

Ejemplares similares